SCHEMBL17659131

SCHEMBL17659131

Oc1ccc(O)c(N2CCN(Cc3cccs3)CC2)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 10/20 0.73
DRD3 P35462 7/20 0.67
DRD2 P14416 5/20 0.67
DRD5 P21918 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 2/20 0.54
MAPT P10636 2/20 0.54
POLB P06746 1/20 0.54
DRD1 P21728 1/20 0.52
HTT P42858 1/20 0.50
PARP1 P09874 1/20 0.47
PARP2 Q9UGN5 1/20 0.47
HSD17B10 Q99714 2/20 0.46
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
ALOX15 P16050 1/20 0.43
GFER P55789 1/20 0.43
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19381643 0.85 DRD4 (0.67) DRD4DRD3DRD2DRD5SMN1; SMN2
SCHEMBL17659673 0.76 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1MAPTHTTPARP1
SCHEMBL17659681 0.75 GAA (0.41) DRD4DRD3DRD2SMN1; SMN2KDM4E
SCHEMBL29236372 0.75 GAA (0.41) DRD4DRD3DRD2SMN1; SMN2KDM4E
SCHEMBL17659005 0.73 DRD4 (0.57) DRD4DRD3DRD2ALDH1A1HSD17B10
SCHEMBL17659683 0.72 MAPK1 (0.52) DRD4DRD3DRD2KDM4EMAPT
SCHEMBL17659123 0.71 DRD2 (0.51) DRD4DRD3DRD2DRD5KDM4E
SCHEMBL7654044 0.71 HTT (0.68) DRD4DRD3DRD2DRD5SMN1; SMN2
SCHEMBL7050984 0.70 HTT (0.72) DRD4DRD3DRD2DRD5SMN1; SMN2
SCHEMBL10679512 0.70 KDM4E (0.63) DRD4DRD3DRD2DRD5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016051799-A1 2-AMINOHYDROQUINONE DERIVATIVE AND TAU AGGREGATION INHIBITOR 学校法人同志社 2016-04-07 WO disclosed